Clinical trial
Randomized, Controlled, Double-blind Study of Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma
NCT03751163 is registered in ClinicalTrials.gov with Fakultas Kedokteran Universitas Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Controlled, Double-blind Study of Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma
- Lead sponsor
- Fakultas Kedokteran Universitas Indonesia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 16, 2016
- Completion date
- April 2, 2017
- Enrollment
- 50 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
melasma